MUC13 Mucoprotein Is a Reliable Diagnostic and Prognostic Marker for Pancreatic Ductal Adenocarcinoma

被引：0
|
作者：
Bibars, Wafi [1 ]
Khan, Sheema [1 ]
Jaggi, Meena [1 ]
Chauhan, Subhash [1 ]
Zafar, Nadeem [1 ]
机构：
[1] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA
来源：
MODERN PATHOLOGY | 2017年 / 30卷
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1775
引用
收藏
页码：442A / 442A
页数：1
相关论文
共 50 条
  • [1] MUC13 Mucoprotein Is a Reliable Diagnostic and Prognostic Marker for Pancreatic Ductal Adenocarcinoma
    Bibars, Wafi
    Khan, Sheema
    Jaggi, Meena
    Chauhan, Subhash
    Zafar, Nadeem
    LABORATORY INVESTIGATION, 2017, 97 : 442A - 442A
  • [2] Clinical significance of MUC13 in pancreatic ductal adenocarcinoma
    Khan, Sheema
    Zafar, Nadeem
    Khan, Shabia S.
    Setua, Saini
    Behrman, Stephen W.
    Stiles, Zachary E.
    Yallapu, Murali M.
    Sahay, Peeyush
    Ghimire, Hemendra
    Ise, Tomoko
    Nagata, Satoshi
    Wang, Lei
    Wan, Jim Y.
    Pradhan, Prabhakar
    Jaggi, Meena
    Chauhan, Subhash C.
    HPB, 2018, 20 (06) : 563 - 572
  • [3] MUC13-An Early Diagnostic Marker for Pancreatic Ductal Adenocarcinoma
    Khan, Sheema
    Behrman, Stephen W.
    Zafar, Nadeem
    Jaggi, Meena
    Chauhan, Subhash C.
    GASTROENTEROLOGY, 2016, 150 (04) : S1255 - S1255
  • [4] Clinicopathological Significance of MUC13 Expression in Pancreatic Ductal Adenocarcinoma (PDAC); the Positive Prognostic Marker and Possible Candidate for Molecular Targeted Therapy
    Marukawa, Katsuji
    Mitsuhashi, Tomoko
    Hatanaka, Yutaka
    Morooka, Asami
    Sato, Daisuke
    Nitta, Takeo
    Nakamura, Toru
    Hirano, Satoshi
    Matsuno, Yoshihiro
    LABORATORY INVESTIGATION, 2016, 96 : 444A - 444A
  • [5] Clinicopathological Significance of MUC13 Expression in Pancreatic Ductal Adenocarcinoma (PDAC); the Positive Prognostic Marker and Possible Candidate for Molecular Targeted Therapy
    Marukawa, Katsuji
    Mitsuhashi, Tonzoko
    Hatanaka, Yutaka
    Morooka, Asami
    Sato, Daisuke
    Nitta, Takeo
    Nakamura, Toru
    Hirano, Satoshi
    Matsuno, Yoshihiro
    MODERN PATHOLOGY, 2016, 29 : 444A - 444A
  • [6] Aberrant MUC13 expression as prognostic marker for gastric cancer
    Oosterlinck, B.
    Breugelmans, T.
    De Man, J.
    Geboes, K.
    Kupcinskas, J.
    Link, A.
    De Winter, B.
    Smet, A.
    HELICOBACTER, 2020, 25 : 54 - 54
  • [7] MUC13 interaction with receptor tyrosine kinase HER2 drives pancreatic ductal adenocarcinoma progression
    Khan, Sheema
    Ebeling, Mara C.
    Sikander, Mohammad
    Yallapu, Murali M.
    Ise, Tomoko
    Nagata, Satoshi
    Behrman, Stephen W.
    Zafar, Nadeem
    Wan, Jim Y.
    Ghimire, Hemendra M.
    Sahay, Peeyush
    Pradhan, Prabhakar
    Jaggi, Meena
    Chauhan, Subhash C.
    CANCER RESEARCH, 2016, 76
  • [8] MUC13 interaction with receptor tyrosine kinase HER2 drives pancreatic ductal adenocarcinoma progression
    S Khan
    M Sikander
    M C Ebeling
    A Ganju
    S Kumari
    M M Yallapu
    B B Hafeez
    T Ise
    S Nagata
    N Zafar
    S W Behrman
    J Y Wan
    H M Ghimire
    P Sahay
    P Pradhan
    S C Chauhan
    M Jaggi
    Oncogene, 2017, 36 : 491 - 500
  • [9] MUC13 Interaction With Receptor Tyrosine Kinase HER2 Drives Pancreatic Ductal Adenocarcinoma Progression
    Khan, Sheema
    Behrman, Stephen W.
    Zafar, Nadeem
    Jaggi, Meena
    Chauhan, Subhash C.
    GASTROENTEROLOGY, 2016, 150 (04) : S1203 - S1203
  • [10] MUC13 interaction with receptor tyrosine kinase HER2 drives pancreatic ductal adenocarcinoma progression
    Khan, S.
    Sikander, M.
    Ebeling, M. C.
    Ganju, A.
    Kumari, S.
    Yallapu, M. M.
    Hafeez, B. B.
    Ise, T.
    Nagata, S.
    Zafar, N.
    Behrman, S. W.
    Wan, J. Y.
    Ghimire, H. M.
    Sahay, P.
    Pradhan, P.
    Chauhan, S. C.
    Jaggi, M.
    ONCOGENE, 2017, 36 (04) : 491 - 500
12345